Abstract
Background and Clinical Significance: Iatrogenic atrophy following intralesional corticosteroid injections represents a rare but potentially disfiguring complication, particularly when administered in the facial region for the treatment of inflammatory acne. Unlike conventional post-acne atrophic scarring, corticosteroid-induced tissue loss involves both dermal and subcutaneous compartments, resulting in a clinically distinct presentation that poses significant therapeutic challenges, with no established consensus on optimal management. Case Presentation: We report the case of a 26-year-old Caucasian female (Fitzpatrick phototype III) presenting with severe iatrogenic facial atrophy of the left cheek, resulting from multiple intralesional corticosteroid injections performed by a previous physician for papulo-pustular acne. The condition had been clinically stable for approximately two years at first evaluation. The patient underwent a stepwise multimodal protocol over approximately 18 months, combining non-ablative fractional laser remodelling (LightScan – Eufoton), Autologous Regenerative Therapy (ART, Seffiller technique, Seffiline srl), hyperdiluted calcium hydroxylapatite (CaHA – Radiesse, Merz Aesthetics) biostimulation, and additional non-ablative fractional photothermolysis sessions, supported by a topical cosmeceutical protocol. Clinician-assessed scar severity improved from Goodman & Baron Grade 3 to Grade 2, and Vancouver Scar Scale score from 4–5/13 to 1–2/13. Global aesthetic improvement was rated as +2 ("Much improved") on the GAIS, with patient satisfaction of 5/5. Conclusions: This case demonstrates that a carefully sequenced multimodal approach combining energy-based devices, biological scaffolds, and biostimulatory agents can achieve substantial and durable correction of iatrogenic steroid-induced facial atrophy, providing a reproducible framework for managing this under-reported and therapeutically challenging condition.

This publication has 15 references indexed in Scilit: